EORI-Search in

Who? Where?

All Information about:

Name	Setfirst Limited
Address	79 New Oxford Street London WC1A 1DG
VAT ID	no VAT ID available
Company No.	02332323 Show on Companies House
Accounts	full last accounts made up to 31 December 2022
Sector (SIC)	70100 - Activities of head offices
Company Register Status	active
KYC Check KYC checks will cover 240 countries and 40 languages for both corporates and individuals: PEP - Any individual that is considered a Politically Exposed Person, from Head of State to Members of Parliament, Members of the Board of State Owned Enterprises or Ambassadors and individuals representing their countries interests abroad. Sanction - Any individual or entity that is (or was) subject to sanctions by either the European Union, the United Nations, the United States Office of Foreign Assets Control and State Department and Her Majesty’s Treasury in the United Kingdom. Financial Regulator - Any individual or entity that has been fined or in some other way subject to action by any financial regulatory body. Law Enforcement - Any individual or entity that has been named in official documentation from Law Enforcement bodies such as the Police or any other agency such as Interpol or the FBI. Also those individuals and entities cited in Court and legal documents of that nature. Adverse Media - Any individual or entity that has been reported in global newspapers, news sites or other media as being involved in financial crime. Other country specific datasets	KYC / PEP / AML request

This data is incorrect?
Sources: Company Register: Companies House (companieshouse.gov.uk)

go to our Search Engine

Quick access

Persons with Significant Control
Companies Controlled by This Company
Officers
Similar VAT Registered Companies

Persons with Significant Control (1)

Source: Companies House

GB Glaxosmithkline Finance Plc Status: Active Notified: 06/04/2016 Companies House Number: 00242686 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

Officers (5)

Source: Companies House

Brown, Julie Belita London, United Kingdom Status: Active Notified: 01/05/2023 Date of Birth: 03/1962 Occupation: Chief Financial Officer Role: Director Country of Residence: United Kingdom Nationality: British

Edinburgh Pharmaceutical Industries Limited, Shewalton Road, Irvine, Ayrshire, Scotland, KA11 5AP Status: Active Notified: 02/03/2001 Role: Director Nationality: British

GB Glaxo Group Limited Gunnels Wood Road, Stevenage, United Kingdom, SG1 2NY Status: Active Notified: 02/03/2001 Role: Corporate-Director Companies House Number: 00305979

Glaxo Group Limited, 980 Great West Road, Brentford, Middlesex, England, TW8 9GS Status: Active Notified: 02/03/2001 Role: Director Nationality: British

Walker, Adam London, United Kingdom Status: Active Notified: 20/02/2015 Date of Birth: 11/1967 Occupation: Director Role: Director Country of Residence: United Kingdom Nationality: British

Companies Controlled by This Company (10)

Galvani Bioelectronics LTD Status: Active Notified: 06/04/2016 Companies House Number: 09984862 Nature of Control

Ownership of shares – More than 50% but not more than 75%

Ownership of voting rights - More than 50% but not more than 75%

Right to appoint and remove directors

GB Glaxochem (UK) Unlimited Status: Active Notified: 06/04/2016 Companies House Number: 04299472 Nature of Control

Ownership of shares – More than 50% but not more than 75%

Ownership of voting rights - More than 50% but not more than 75%

Right to appoint and remove directors

GB Glaxosmithkline Holdings (Ireland) Limited Status: Active Notified: 06/04/2016 Companies House Number: 09163001 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Glaxosmithkline International Limited Status: Active Notified: 06/04/2016 Companies House Number: 02298366 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Glaxosmithkline International Limited Status: Active Notified: 06/04/2016 Companies House Number: 02298366 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Glaxosmithkline Investment Holdings Limited Status: Active Notified: 06/04/2016 Companies House Number: 07089743 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Glaxosmithkline Investment Services Limited Status: Active Notified: 06/04/2016 Companies House Number: 06968741 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Smithkline Beecham (Investments) Limited Status: Active Notified: 06/04/2016 Companies House Number: 00302065 Nature of Control

Ownership of shares – More than 25% but not more than 50%

Ownership of voting rights - More than 25% but not more than 50%

Right to appoint and remove directors

GB Stiefel Laboratories (Maidenhead) Limited Status: Active Notified: 06/04/2016 Companies House Number: 05354860 Nature of Control

Ownership of shares - 75% or more

Ownership of voting rights - 75% or more

Right to appoint and remove directors

GB Stiefel Laboratories (U.K.) LTD Status: Active Notified: 06/04/2016 Companies House Number: 00831160 Nature of Control

Ownership of shares – More than 50% but not more than 75%

Ownership of voting rights - More than 50% but not more than 75%

Right to appoint and remove directors

All Information about:

Setfirst Limited

Quick access

Persons with Significant Control (1)

Officers (5)

Companies Controlled by This Company (10)